The tariff classification of Olmesartan Medoxomil Tablets and Spironolactone Tablets in dosage form, from India and China, respectively
Reasoning
The tariff classification of Olmesartan Medoxomil Tablets and Spironolactone Tablets in dosage form, from India and China, respectively
Cite this ruling
CBP Ruling N276537 (3004390050): The tariff classification of Olmesartan Medoxomil Tablets and Spironolactone Tablets in dosage form, from India and China, respectively
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300439
The tariff classification and country of origin of Calcitonin Salmon Injection, USP in dosage form
The tariff classification of Leuprolide Acetate Injection in dosage form, from India
The tariff classification of Liraglutide Injection Pen in dosage form, from China
The tariff classification of ORABLOC® (Articaine Hydrochloride 4% and Epinephrine 1100,000 and 1200,000) Injection in dosage form, from Italy
The tariff classification of Estradiol Tablets in dosage form, from India